Adverse Effects

Brain Cancer

HER2-Positive Breast Cancer

Triple-Negative Breast Cancer

Breast Cancer

Colorectal Cancer

Esophageal Cancer

Gastric Cancer

Liver Cancer

Pancreatic Cancer

Gastrointestinal Cancer

Bladder Cancer

Kidney Cancer

Prostate Cancer

Genitourinary Cancers

Cervical Cancer

Endometrial Cancer

Ovarian Cancer

Gynecologic Cancers

Head & Neck Cancer

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Hematologic Oncology

Vaccines

Infection

Leukemia

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

Lung Cancer

Lymphoma

Neuroendocrine Tumors

Oncology

Pediatric Cancers

Radiation Oncology

Sarcoma

Screening

Skin Cancer & Melanoma

Surgery

Thyroid Cancer

News

Global Bulletin

All News

FDA Approval Alert

Women in Oncology

Media

Expert Interviews

Around the Practice

Between the Lines

Face Off

From All Angles

Meeting of the Minds

OncView

Podcasts

Training Academy

Treatment Algorithms with the Oncology Brothers

Videos

Conferences

Publications

All Journals

Editorial Board

For Authors

Year in Review

Events

Frontline Forum

Satellite Sessions

CME/CE

Resources

Awareness Month

Interactive Tools

Nurse Practitioners/Physician's Assistants

Partners

Career Center

Subscribe

CancerNetwork is home to the journal Oncology & provides insights on the screening, early detection, diagnosis, treatment and prevention of cancers.

About

Advertise

CureToday.com

OncLive.com

OncNursingNews.com

TargetedOnc.com

Editorial

Contact

Terms and Conditions

Privacy

Do Not Sell My Personal Information

CancerNetwork - Oncology News and Clinical Expertise

Facebook

LinkedIn

Youtube

Spotlight

Clinical

Genitourinary Cancer

Gynecologic Cancer

Hematology

Skin Cancer

1rem

View

Treatment Options in Metastatic Castration-Sensitive Prostate Cancer

Clinical Consult

In this program Drs. Atish Choudhury and Bobby Liaw discuss recent updates from ASCO, ASCO GU and AUA meetings on long-term safety and efficacy data in patients with metastatic castration-sensitive prostate cancer (mCSPC) and the importance of patient communication and quality of life while on treatment.

Dr. Atish Choudhury provides an overview of advances and changes in management of patients with metastatic castration sensitive prostate cancer (mCSPC) in the last decade.

Diagnosis and Management of mCSPC

Dr. Choudhury discusses treatment considerations and treatment options for mCSPC.

Treatment Options and Considerations in mCSPC

Dr. Liaw shares the role disease burden and other factors play in treatment selection.

Disease Burden and Treatment Selection in mCSPC

A prostate cancer expert shares long-term data with androgen receptor pathway inhibitors in mCSPC.

Long-Term Data with Androgen Receptor Pathway Inhibitors

Dr. Atish Choudhury discusses safety features to keep in mind when choosing androgen receptor pathway inhibitors.

Safety Considerations in mCSPC and Selection of Androgen Receptor Pathway Inhibitors

Dr Bobby Liaw talks about relationship between treatment duration, dosing and efficacy.

Duration of Treatment for Patients with mCSPC

Dr Liaw discusses ways to measure response to treatment and what recent data regarding PSA kinetics has shown.

Response to Prostate Cancer Treatments

A prostate cancer expert shares rationale for his preferences and choices while sequencing therapies in prostate cancer.

Sequencing in mCSPC

Dr. Bobby Liaw discusses importance of setting expectations regarding common side effects and challenges patients might experiences with treatment.

Challenges with Prostate Cancer Treatments

A prostate cancer expert reemphasizes importance of open communication between patients and healthcare providers.

Patient-Healthcare Provider Communication Regarding Challenges

Prostate cancer experts share exciting changes to the prostate cancer treatment landscape and how we are now better equipped to take care of patients with prostate cancer.

Trends in Prostate Cancer Care

Dr Choudhury shares recent updates from 2021 meetings including ASCO GU, AUA, and ESMO.

Recent Updates in Prostate Cancer Care

A prostate cancer expert discusses promising and emerging treatments for prostate cancer.

Evolving Treatment Landscape in Metastatic Prostate Cancer

 provides expert commentary and insights on designated therapeutic topics.

Diagnosis and Management of mCSPC

EP: 1.Diagnosis and Management of mCSPC

EP: 2.Treatment Options and Considerations in mCSPC

EP: 3.Disease Burden and Treatment Selection in mCSPC

EP: 4.Long-Term Data with Androgen Receptor Pathway Inhibitors

EP: 5.Safety Considerations in mCSPC and Selection of Androgen Receptor Pathway Inhibitors

EP: 6.Duration of Treatment for Patients with mCSPC

EP: 7.Response to Prostate Cancer Treatments

EP: 8.Sequencing in mCSPC

EP: 9.Challenges with Prostate Cancer Treatments

EP: 10.Patient-Healthcare Provider Communication Regarding Challenges

EP: 11.Trends in Prostate Cancer Care

EP: 12.Recent Updates in Prostate Cancer Care

EP: 13.Evolving Treatment Landscape in Metastatic Prostate Cancer

Newsletter